WIPO publishes P&G patent for 'menstrual pant'

Nevin Barich

ALEXANDRIA, Virginia , October 4, 2013 (U.S. Fed News) – Publication No. WO/2013/148749 was published on Oct. 3.

Title of the invention: "MENSTRUAL PANT."

Applicants: THE PROCTER & GAMBLE COMPANY (US).

Inventors: Brian Francis Gray (US), Brett Darren Seitz (US), Andres Ernesto Velarde (US) and Bruce William Lavash (US).

According to the abstract* posted by the World Intellectual Property Organization: "A system including a menstrual pant and an absorbent article. The menstrual pant has a front part; a back part; a crotch part provided so as to bridge between the front part and the back part, the crotch being utilized for fitting a sanitary napkin; a waist opening part provided in an upper edge of the front part and an upper edge of the back part; a pair of leg openings provided below both side edges of the front part and both side edges of the back part; and a lifting strip disposed along the longitudinal centerline in the rear portion. The menstrual pant apply body-contacting pressures to the wearer's body longitudinally through the crotch of 25 g/cm2 to 100 g/cm2. The absorbent article has a topsheet having a body facing surface; a backsheet joined to said topsheet; and an absorbent core disposed between said topsheet and said backsheet. The absorbent article exhibits a 30-minute Vertical Wicking Height of at least about 12 cm."

The patent was filed on March 27 under Application No. PCT/US2013/033972.

*For further information, including images, charts and tables, please visit: http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2013148749

For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com

(c) 2013 US Fed News (HT Syndication)

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.